Investors
Delphi Diagnostics is providing the next generation of diagnostics to personalize breast cancer treatment decisions. Using the resources below, investors can learn more about our company and which events we will be attending.
Events & Conferences
Delphi participates in several industry and investor-related events throughout the year. Contact us to connect at one of these events.
Investor Overview
Contact us to learn more and receive a full copy of the investor overview
Latest News
The most recent news from Delphi Diagnostics is published in press releases, find the full list of press releases on our news page.
GEICAM, Unicancer and Delphi Diagnostics Drive a Joint Analysis to Personalize Adjuvant Chemotherapy in Early Breast Cancer
Contact Us
Want to learn more about the Endocrine Activity Index (EAI) or Delphi Diagnostics?